CPhI Panel to Analyse New Industry Perspectives and Innovations Ahead of Predictive 2014 Annual Report

Amsterdam (ots/PRNewswire) -

New panel additions Patheon, Almac and Arevepharma to provide
global

insights from the contract services sector

CPhI expert panel members for 2014:

1) Prabir Basu, President at Pharma Manufacturing
2) Girish Malhotra, President & Founder, Epcot International
[http://www.pharmaevolution.com/bloggers.asp#Girish_Malhotra ]
3) Hedley Rees, Managing Director at PharmaFlow Ltd
4) Sam Venugopal, Director in the Healthcare Practice at PWC
5) William Botha, Consultant and Founder Interlean
6) Emil Ciurczak, President at Doramaxx Consulting
7) Dilip G Shah, CEO of Vision Consulting Group and a regulatory expert
8) Vijay Shah, COO at Piramal Enterprises and pharma business lead
9) Hendrik Baumann, CEO of Arevipharma
10) Lukas Utiger, President of Fine Chemicals and Integrated Offering at DSM
11) Alan Armstrong (CEO) and Douglas Cookson (VP corporate marketing), Almac
12) Brian Carlin, Director Open Innovation at FMC
13) Ali Afnan, President at Step Change Pharma

CPhI Worldwide [http://www.cphi.com ], organised by UBM Live, has
announced its full line up of confirmed expert industry panel members
for 2014, building on the huge success of the CPhI annual report
launched at CPhI Worldwide in October 2013.

(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

This year's panel sees the return of ten thought leaders with the
addition of three new members, covering the entire pharmaceutical
supply chain from R&D through to finished products, regulatory
requirements and economic implications. Additionally, this year panel
members are utilising their market insights and analysis year round
in the CPhI Pharma Insights series, which cover individual topics and
developments across the industry - including the released R&D,
manufacturing and Turkey reports, with a United States report due out
imminently.

The new panel members are all from the contract manufacturing
arena, with heavyweights Alan Armonstrong (CEO) and Douglas Cookson
(VP corporate marketing) from Almac. Hendrik Baumann, the current CEO
of Arevipharma, leverages his expertise within the German market and
across API manufacturing. Lukas Utiger - president of Fine Chemicals
and Integrated Offering at DSM - will lend his insights in the
commercialization of pharmaceuticals. Collectively they provide a
global overview of outsourcing with Almac and Arevipharma focusing on
the international market from a European stance and DSM from a US
perspective.

The returning members feature expertise across API and
manufacturing efficiencies (Girish Malhotra) to quality systems and
supply chain activities (Sam Venugopal), with insights also provided
from some of the sectors biggest names and innovators, like Piramal's
Vijay Shah. Across supply chain issues, the panel will leverage the
knowledge of Hedley Rees, whilst Prabir Basu, formerly of the
National Institute for Pharmaceutical Technology and Education
(NIPTE), will focus on the industry's approach to innovation.

Regulatory expert, predominantly focussed on the Indian market,
Dilip Shah also returns covering the intellectual property rules
around innovation. Brian Carlin, who chairs IPEC Americas Excipient
Qbd Committee, is also returning. He serves as the director of Open
innovation at FMC and received the IPEC One World Regulatory
Excellence Award in 2014. The winner of several FDA Commissioner
Awards, Dr. Ali Afnan is another well-respected industry influencer
and was a key contributor to the drafting and finalising of the
current FDA Process Validation Guidance.

Emil Ciurczak, previously a member of the FDA's PAT committee and
president of Doramaxx Consulting [http://www.linkedin.com/search?sea
rch=&company=Doramaxx+Consulting&sortCriteria=R&keepFacets=true&trk=p
rof-exp-company-name ] draws upon his expertise across PAT, QbD and
spectroscopy. Finally, William Botha, a respected trainer and mentor
in manufacturing is also retuning to the panel; he is fluent in FDA
regulations, including GDP and GMP.

Last year's report examined major issues and developments across
the industry including regulatory challenges from a globalised
industry, cost savings through QbD and PAT, to the effect
breakthrough drugs like ADCs will have on overcoming future disease
pathologies.

"The 2013 report was hugely successful with our experts providing
insights into how the industry will adapt in the near future. This
year we have been able to see the progress the industry has made
along with the new challenges and threats ahead. Our experts will
examine future potential breakthrough drugs, regulatory risks and
supply chain issues. This year we also have representation from
leading global CDMO players, Patheon, Almac and Arevipharma- adding a
further depth of perspectives and providing a completely holistic
picture of the global pharma landscape." commented Chris Kilbee,
Group Director Pharma at CPhI.

The 2014 annual report features a collection of in depth essays
from each panel member - with experts again given carte blanche to
prophesize how the industry will look and operate in the future from
both an economic and practical perspective.

Kilbee added, "I am very pleased that we have been able to include
in our panel many of the major figures in the industry, as they
provide hundreds of years of experience both individually and
collectively. The panel's ability to provide a realistic approach to
problem solving, coupled with an international outlook is essential
in advancing market dynamics."

For more information, please contact: cphi@ubm.com

About CPhI

CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage.
Through exhibitions, conferences and online communities, CPhI brings
together more than 100,000 pharmaceutical professionals each year to
network, identify business opportunities and expand the global
market. CPhI hosts events in Europe, Korea, China, India, Japan,
Southeast Asia, Istanbul, Russia and South America and co-locates
with ICSE for contract services, P-MEC for machinery, equipment &
technology, InnoPack for pharmaceutical packaging and BioPh for
biopharma. CPhI provides an online buyer & supplier directory at
CPhI-Online.com.

For more information visit: http://www.cphi.com

The UBM Live annual schedule of Pharmaceutical events also
includes; CPhI South America (5-7 August 2014 at Expo Centre Norte,
Sao Paulo- Brazil); CPhI, ICSE Korea (2-3 September, 2014 at the
COEX- Seoul, South Korea); CPhI, ICSE, P-MEC and InnoPack Worldwide ;
CPhI and P-MEC India (2-4 December, 2014 at the Bombay Exhibition
Centre- Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan . CPhI
Russia and IPhEB (27-29 April, 2015 at the VVC, Pavilion Nr 75,
Moscow Russia); CPhI, P-MEC and Innopack South East Asia (26-28 May,
2015 at the Jakarta International Expo- Jakarta, Indonesia); CPhI
Istanbul (3-5 June, 2015, at the Lutfi Kirdar Convention and
Exhibition Centre- Turkey); CPhI, Hi and Fi, ICSE, P-MEC, BioPh and
LabWorld China (23-25 June, 2014 at SNIEC- Shanghai, China)

About UBM Live

UBM Live connects people and creates opportunities for companies
across five continents to develop new business, meet customers,
launch new products, promote their brands, and expand their market.
Through premier brands such as TFM&A, Internet World, IFSEC, MD&M,
CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM
Live exhibitions, conferences, awards programs, publications,
Websites, and training and certification programs are an integral
part of the marketing plans of companies across more than 20 industry
sectors.

For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44(0)207-203-6745 / 6740
E: a.heeley@defacto.com / t.jervis@defacto.com

Photo:
http://photos.prnewswire.com/prnh/20130723/629764-a

ots Originaltext: UBM Live
Im Internet recherchierbar: http://www.presseportal.de